Rhythm Biosciences Ltd
ASX:RHY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Rhythm Biosciences Ltd
Free Cash Flow
Rhythm Biosciences Ltd
Free Cash Flow Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Rhythm Biosciences Ltd
ASX:RHY
|
Free Cash Flow
-AU$6.1m
|
CAGR 3-Years
0%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
|
|
Sonic Healthcare Ltd
ASX:SHL
|
Free Cash Flow
AU$745.5m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
11%
|
|
|
Integral Diagnostics Ltd
ASX:IDX
|
Free Cash Flow
AU$26.7m
|
CAGR 3-Years
17%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
|
|
Australian Clinical Labs Ltd
ASX:ACL
|
Free Cash Flow
AU$174.4m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
|
|
Apiam Animal Health Ltd
ASX:AHX
|
Free Cash Flow
AU$10.8m
|
CAGR 3-Years
2%
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
|
|
H
|
Healius Ltd
ASX:HLS
|
Free Cash Flow
AU$125.7m
|
CAGR 3-Years
-26%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
15%
|
|
Rhythm Biosciences Ltd
Glance View
Rhythm Biosciences Ltd. engages in the research, development, and commercialization of medical diagnostics technologies. The company is headquartered in Melbourne, Victoria. The company went IPO on 2017-12-07. The firm is engaged in developing and commercializing Australian medical diagnostics technology for sale in domestic and international markets. The Company’s development stage product, ColoSTAT focuses to provide early detection test for colorectal cancer. The Company’s ColoSTAT blood test is used to detect colorectal cancer at all stages, including the early ones. The firm's subsidiary includes Vision Tech Bio Pty Ltd.
See Also
What is Rhythm Biosciences Ltd's Free Cash Flow?
Free Cash Flow
-6.1m
AUD
Based on the financial report for Dec 31, 2025, Rhythm Biosciences Ltd's Free Cash Flow amounts to -6.1m AUD.
What is Rhythm Biosciences Ltd's Free Cash Flow growth rate?
Free Cash Flow CAGR 5Y
-13%
Over the last year, the Free Cash Flow growth was -190%.
